John S. Ward

446 total citations
10 papers, 364 citations indexed

About

John S. Ward is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, John S. Ward has authored 10 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 2 papers in Pharmacology. Recurrent topics in John S. Ward's work include Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neuropeptides and Animal Physiology (2 papers). John S. Ward is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neuropeptides and Animal Physiology (2 papers). John S. Ward collaborates with scholars based in Denmark and United States. John S. Ward's co-authors include Malcolm J. Sheardown, Preben H. Olesen, Per Sauerberg, Charles H. Mitch, H E Shannon, Frank P. Bymaster, Andrew Pike, Svend Treppendahl, Tage Honoré and Barry D. Sawyer and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

John S. Ward

9 papers receiving 351 citations

Peers

John S. Ward

MB

CMN

PHARM

PHYSI

OC

Luc Peeters Belgium

Christopher L. Chio United States

G.B. Schiavi Italy

E. FALCH Denmark

Jeanette Watson United Kingdom

Delphine S. Dupuis France

Alfred Lanzafame Australia

Hermann J. Gerhards Germany

Lee-Yuan Liu-Chen United States

Andrés G. Fernández Spain

Luc Peeters Belgium

John S. Ward

357 ×1.3

MB

307 ×1.5

CMN

47 ×0.9

PHARM

34 ×0.7

PHYSI

21 ×0.5

OC

Citations per year, relative to John S. Ward John S. Ward (= 1×) peers Luc Peeters

Countries citing papers authored by John S. Ward

Since Specialization

Citations

This map shows the geographic impact of John S. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Ward more than expected).

Fields of papers citing papers by John S. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Ward. The network helps show where John S. Ward may publish in the future.

Co-authorship network of co-authors of John S. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Ward. A scholar is included among the top collaborators of John S. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Ward. John S. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Rasmussen, Thøger, Anders Fink‐Jensen, Per Sauerberg, et al.. (2001). The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance. Schizophrenia Research. 49(1-2). 193–201. 31 indexed citations

2.

Sheardown, Malcolm J., H E Shannon, Michael D.B. Swedberg, et al.. (1997). M1 Receptor Agonist Activity Is Not a Requirement for Muscarinic Antinociception. Journal of Pharmacology and Experimental Therapeutics. 281(2). 868–875. 42 indexed citations

3.

Swedberg, Michael D.B., H E Shannon, Malcolm J. Sheardown, et al.. (1997). Anticonvulsant effects of muscarinics. Life Sciences. 60(13-14). 1202–1202.

4.

Ward, John S., David O. Calligaro, Frank P. Bymaster, et al.. (1995). Functionally selective M1 muscarinic agonists. 3. Side chain and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles. Journal of Medicinal Chemistry. 38(18). 3469–3481. 24 indexed citations

5.

DeLapp, Neil W., et al.. (1995). The M1 agonist xanomeline potently stimulates APPs release from CHO-m1 cells. Life Sciences. 56(11-12). 1024–1024. 1 indexed citations

6.

Sauerberg, Per, Preben H. Olesen, Malcolm J. Sheardown, et al.. (1995). Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogs. Life Sciences. 56(11-12). 807–814. 17 indexed citations

7.

Swedberg, Michael D.B., Malcolm J. Sheardown, Per Sauerberg, et al.. (1995). NNC 11-1053 / LY 297802: An antinociceptive orally acting muscarinic agonist in mouse and rat. Life Sciences. 56(11-12). 1047–1047. 6 indexed citations

8.

Shannon, H E, Frank P. Bymaster, David O. Calligaro, et al.. (1994). Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.. Journal of Pharmacology and Experimental Therapeutics. 269(1). 271–281. 80 indexed citations

9.

Sauerberg, Per, Preben H. Olesen, Svend Treppendahl, et al.. (1992). Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines. Journal of Medicinal Chemistry. 35(12). 2274–2283. 131 indexed citations

10.

Shannon, H E, et al.. (1990). Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.. Journal of Pharmacology and Experimental Therapeutics. 255(3). 1071–1077. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact